Amalgamated Bank’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-13,266
| Closed | -$1.13M | – | 1845 |
|
|
2019
Q4 | $1.13M | Buy |
13,266
+1,732
| +15% | +$116K | 0.02% | 755 |
|
|
2019
Q3 | $577K | Sell |
11,534
-226
| -2% | -$9.02K | 0.01% | 978 |
|
|
2019
Q2 | $429K | Buy |
11,760
+780
| +7% | +$25.5K | 0.01% | 1155 |
|
|
2019
Q1 | $307K | Buy |
10,980
+212
| +2% | +$5K | 0.01% | 1251 |
|
|
2018
Q4 | $206K | Buy |
+10,768
| New | +$250K | 0.01% | 1397 |
|
|
2018
Q3 | – | Sell |
-11,085
| Closed | -$407K | – | 1707 |
|
|
2018
Q2 | $407K | Buy |
11,085
+1,136
| +11% | +$36.9K | 0.01% | 1140 |
|
|
2018
Q1 | $328K | Sell |
9,949
-73
| -0.7% | -$2.28K | 0.01% | 1165 |
|
|
2017
Q4 | $274K | Buy |
10,022
+607
| +6% | +$18.7K | 0.01% | 1311 |
|
|
2017
Q3 | $349K | Sell |
9,415
-160
| -2% | -$5.9K | 0.01% | 1119 |
|
|
2017
Q2 | $364K | Buy |
9,575
+629
| +7% | +$28K | 0.01% | 1090 |
|
|
2017
Q1 | $437K | Sell |
8,946
-11
| -0.1% | -$502 | 0.02% | 912 |
|
|
2016
Q4 | $304K | Buy |
8,957
+1,140
| +15% | +$40.4K | 0.01% | 1131 |
|
|
2016
Q3 | $295K | Sell |
7,817
-1
| -0% | -$38 | 0.02% | 1028 |
|
|
2016
Q2 | $289K | Buy |
7,818
+726
| +10% | +$25.6K | 0.02% | 1042 |
|
|
2016
Q1 | $225K | Buy |
7,092
+671
| +10% | +$21.9K | 0.02% | 1069 |
|
|
2015
Q4 | $240K | Sell |
6,421
-492
| -7% | -$18.6K | 0.03% | 950 |
|
|
2015
Q3 | $262K | Buy |
+6,913
| New | +$243K | 0.03% | 978 |
|
|
2014
Q1 | – | Sell |
-6,561
| Closed | -$253K | – | 860 |
|
|
2013
Q4 | $253K | Buy |
+6,561
| New | +$235K | 0.04% | 650 |
|
Other funds holding MDCO
Amalgamated Bank's MDCO Position: Q1 2020 in Review
Amalgamated Bank sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 13,266 shares — an estimated $1.13M sold.
Amalgamated Bank first reported a position in MDCO in Q4 2013 and held it in 18 quarters. The position peaked at $1.13M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Amalgamated Bank reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Amalgamated Bank sold 13,266 Medicines Co shares in Q1 2020, an estimated $1.13M.
- Amalgamated Bank first reported a position in Medicines Co in Q4 2013 and held it in 18 quarters.
- Amalgamated Bank's Medicines Co position peaked at $1.13M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Amalgamated Bank's 13F filing for Q1 2020, filed 13 May 2020.